SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced a new product for DNA Analysis: the HumanOmni1-Quad BeadChip. With over four million data points on a single BeadChip, this array includes up-to-date content for all major classes of genetic variation for the study of human disease. The BeadChip utilizes tagSNPs from all three phases of the International HapMap Project and offers premier coverage of known regions of copy number variation (CNV) and SNPs of known disease association. In addition, the HumanOmni1-Quad BeadChip is the first commercially-available product to offer content derived from the 1,000 Genomes Project. The format of the HumanOmni1-Quad BeadChip supports simultaneous genotyping of four samples which increases throughput and decreases the per sample price. First customer shipments of HumanOmni1-Quad BeadChips are expected in June 2009.
